Enliven Therapeutics at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Enliven Therapeutics exhibits at Booth 557 at ASH 2026 in New Orleans. Enliven Therapeutics supports a symposium on chronic myeloid leukemia across the whole course of treatment. It covers choosing therapy, tracking response with molecular monitoring and protecting quality of life over the long term.
| Organization | ASH 2026 Attendance |
|---|---|
Enliven Therapeutics Boulder, CO | |
Clinical-stage precision oncology company developing kinase inhibitors, including ELVN-001 for chronic myeloid leukemia. | Booth Exhibiting at Booth 557 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm Symposium Fri Dec 11 11:00am–2:00pm CML Treatment Continuum: Optimizing Therapy Selection, Molecular Monitoring, And Long-Term Quality of Life First-line drug choice, resistance, long-term side effects, and treatment-free remission in chronic myeloid leukemia, plus pipeline agents. |
Find decision makers at Enliven Therapeutics
Tell us what you sell and we’ll find the people at Enliven Therapeutics most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction